ZNF268 anticorps (AA 151-250) (Cy7)
Aperçu rapide pour ZNF268 anticorps (AA 151-250) (Cy7) (ABIN2180358)
Antigène
Voir toutes ZNF268 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 151-250
-
Fonction
- ZNF268 Polyclonal Antibody, Cy7 Conjugated
-
Réactivité croisée
- Souris
-
Homologie
- Human
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human ZNF268
-
Isotype
- IgG
-
-
-
-
Indications d'application
- IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- ZNF268 (Zinc Finger Protein 268 (ZNF268))
-
Autre désignation
- ZNF268
-
Sujet
-
Synonyms: HZF3, Zinc finger protein 268, Zinc finger protein HZF3, ZNF268
Background: Isoform 1: Acts as a transcriptional repressor. Inhibits erythroid differentiation and tumor cell proliferation. Plays a role during ovarian cancer development and progression. Isoform 2: Contributes to cervical carcinogenesis in part through the TNF-alpha-induced NF-kappa-B signaling pathway by interacting with the I-kappa-B-kinase (IKK) core complex.
-
ID gène
- 10795
-
UniProt
- Q14587
Antigène
-